References
- Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54e42; quiz e30.
- Norgard BM, Nielsen J, Fonager K, et al. The incidence of ulcerative colitis (1995–2011) and Crohn’s disease (1995–2012) – based on nationwide Danish registry data. J Crohns Colitis. 2014;8:1274–1280.
- Sjoberg D, Holmstrom T, Larsson M, et al. Incidence and natural history of ulcerative colitis in the Uppsala region of Sweden 2005–2009 – results from the IBD cohort of the Uppsala region (ICURE). J Crohns Colitis. 2013;7:e351–e357.
- Sjoberg D, Holmstrom T, Larsson M, et al. Incidence and clinical course of Crohn’s disease during the first year – results from the IBD cohort of the Uppsala region (ICURE) of Sweden 2005–2009. J Crohns Colitis. 2014;8:215–222.
- Zhulina Y, Udumyan R, Henriksson I, et al. Temporal trends in non-structuring and non-penetrating behavior at diagnosis of Crohn’s disease in Orebro, Sweden: a population-based retrospective study. J Crohns Colitis. 2014;8:1653–1660.
- Busch K, Ludvigsson JF, Ekstrom-Smedby K, et al. Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study. Aliment Pharmacol Ther. 2014;39:57–68.
- Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish National Inpatient Register. BMC Public Health. 2011;11:450.
- Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, et al. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24:659–667.
- Swedish Inflammatory Bowel Disease Registry. Available from: www.swibreg.se.
- Ludvigsson JF, Myrelid P. [SWIBREG –a new version of national IBD registry]. Lakartidningen. 2009;106:3014–3015.
- Wettermark B, Hammar N, Fored CM, et al. The new Swedish prescribed drug register–opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16:726–735.
- Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5A–36A.
- Munkholm P. Crohn’s disease-occurrence, course and prognosis. An epidemiologic cohort-study. Dan Med Bull. 1997;44:287–302.
- Langholz E. Ulcerative colitis. An epidemiological study based on a regional inception cohort, with special reference to disease course and prognosis. Dan Med Bull. 1999;46:400–415.
- Ludvigsson JF, Haberg SE, Knudsen GP, et al. Ethical aspects of registry-based research in the Nordic countries. Clin Epidemiol. 2015;7:491–508.
- Fagerland MW, Lydersen S, Laake P. Recommended tests and confidence intervals for paired binomial proportions. Stat Med. 2014;33:2850–2875.
- Waldenlind K, Eriksson JK, Grewin B, et al. Validation of the rheumatoid arthritis diagnosis in the Swedish National Patient Register: a cohort study from Stockholm county. BMC Musculoskelet Disord. 2014;15:432.
- Lindstrom U, Exarchou S, Sigurdardottir V, et al. Validity of ankylosing spondylitis and undifferentiated spondyloarthritis diagnoses in the Swedish National Patient Register. Scand J Rheumatol. 2015;44:369–76. [Epub ahead of print].
- Dignass A, Eliakim R, Magro F, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis. 2012;6:965–990.
- van Assche G, Dignass A, Panes J, et al. The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis. J Crohns Colitis. 2010;4:7–27.